tiprankstipranks
Hologic’s Mixed Q2 Performance and Revised Earnings Guidance Lead to Hold Rating
PremiumRatingsHologic’s Mixed Q2 Performance and Revised Earnings Guidance Lead to Hold Rating
4d ago
Hologic Exceeds Revenue Guidance Amid Challenges
Premium
Company Announcements
Hologic Exceeds Revenue Guidance Amid Challenges
5d ago
Hologic sees Q3 EPS $1.04-$1.07, consensus $1.10
Premium
The Fly
Hologic sees Q3 EPS $1.04-$1.07, consensus $1.10
5d ago
Hologic price target lowered to $75 from $83 at Mizuho
PremiumThe FlyHologic price target lowered to $75 from $83 at Mizuho
20d ago
Hologic price target lowered to $70 from $86 at BofA
Premium
The Fly
Hologic price target lowered to $70 from $86 at BofA
22d ago
Hologic price target lowered to $75 from $83 at RBC Capital
Premium
The Fly
Hologic price target lowered to $75 from $83 at RBC Capital
28d ago
Hologic downgraded to Hold from Buy at Argus
PremiumThe FlyHologic downgraded to Hold from Buy at Argus
2M ago
Hologic obtains CE Mark for Affirm Contrast Biopsy Software
Premium
The Fly
Hologic obtains CE Mark for Affirm Contrast Biopsy Software
3M ago
Hologic announces FDA clearance of Aptima SARS-CoV-2 assay
Premium
The Fly
Hologic announces FDA clearance of Aptima SARS-CoV-2 assay
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100